Answers are grounded in this paper and cite their sources.
To the Editor: An adolescent boy with Crohn's disease and enterocutaneous fistulas had a response to treatment with granulocyte colony-stimulating factor (filgrastim) after all standard treatments ...
No takes yet. Share an insight, caveat, or question.
Vaughan et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: